C14 - From the CLEOPATRA study to real life: preliminary results from the G.O.N.O. SUPER trial

Autor: Garrone, O., Cursano, M.C., De Angelis, C., Giarratano, T., Saggia, C., Beano, A., Cazzaniga, M., La Verde, N., Milani, A., Collovà, E., Coltelli, L., de Conciliis, E., Vandone, A.M., Airoldi, M., D'Onofrio, L., Bertolini, I., Guarneri, V., Donadio, M., Riva, F., Merlano, M.C.

Publikováno v: In Annals of Oncology October 2017 28 Supplement 6:vi28-vi29

Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study.

Autor: Cava E; Unit of Dietetic and Clinical Nutrition, San Camillo-Forlanini Hospital, 00149 Rome, Italy., Spadaccini D; Department of Health Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy., Aimaretti G; Department of Health Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; SCDU Endocrinology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy., Marzullo P; Department of Health Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; SCDU Endocrinology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy., Cavigiolo B; SCDU Endocrinology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy., Farinelli D; Unit of Dietetic and Clinical Nutrition, University Hospital 'Maggiore della Carità', 28100 Novara, Italy., Gennari A; Division of Oncology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy., Saggia C; Division of Oncology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Eastern Piedmont, Via Solaroli 17, 28100 Novara, Italy., Carbonelli MG; Unit of Dietetic and Clinical Nutrition, San Camillo-Forlanini Hospital, 00149 Rome, Italy., Riso S; Unit of Dietetic and Clinical Nutrition, University Hospital 'Maggiore della Carità', 28100 Novara, Italy., Prodam F; Department of Health Sciences, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.; SCDU Endocrinology, University Hospital 'Maggiore della Carità', Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 02; Vol. 15 (17). Date of Electronic Publication: 2023 Sep 02.

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Autor: Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, Falci C, V., Giarratano, T, Mcmahon, L, De Salvo GL, Dieci, Mv, Maiorana, A, Ficarra, G, Caggia, F, Grisolia, D, Bartolini, S, Lorusso, V, Ardito, R, Tartarone, A, Vanella, P, Taverniti, C, Porpiglia, M, Spanu, Pg, Biglia, N, Andreis, D, Piancastelli, A, Fedeli, A, Parra, Hs, Gambaro, Ar, Romito, S, Malossi, A, Gori, S, Miglietta, L, Del Mastro, L, Amoroso, D, Mansutti, M, Generali, D, Prati, G, Bertolini, A, Berardi, R, Zanni, A, Cottafavi, L, Bologna, A, Naso, G, Pancotti, A, Farci, D, Zoboli, A, Silva, R, Laudadio, L, Bordonaro, R, Marenco, D, Dongiovanni, V, Baldini, E, Saggia, C, Gorzegno, G, Cariello, A, Biganzoli, L, Rampello, E.

Publikováno v: Annals of Oncology. 29:2328-2333

Background: Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended trastuzumab exposure is under investigation. The short-HER study was aimed to assess the non-inferiority

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61f781b7e9350a5669985b12e94ae5c
https://doi.org/10.1093/annonc/mdy414

159P Peripheral T-lymphocytes senescence and response to neoadjuvant therapy (NAT) in operable breast cancer (BC)

Autor: D'Avanzo, F., Rossi, V., Saggia, C., Platini, F., Borra, G., Martini, V., Rua, A., Gioffi, E., Branni, C., Maggiora, P.M., Tassone, A., Varughese, F.M., Ram Vachanaram, A., Ben Ayed, R., Angelillo, C., Barcellini, A., Boldorini, R., Dodaro, I., Ferrante, D., Gennari, A.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S611-S611

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

Autor: Garrigós L; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Saura C; Head Breast Cancer Unit, Vall d'Hebron University Hospital and Principal Investigator Breast Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebrón 119-129, 08035 Barcelona, Spain., Martinez-Vila C; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Pistilli B; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Lambertini M; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Policlinico San Martino Hospital, Genoa, Italy., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Lumsden A; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Pernas S; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet, Spain., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Viñas G; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Sanchez A; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Santoro A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Perone Y; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Chester J; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Iglesias M; Department of Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain., Betti M; Research Infrastructure, Research and Innovation Department, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo', Alessandria, Italy., Vincenzi B; Department of Oncology, University 'Campus Bio-Medico', Rome, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy., Guida A; Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy., Wuerstlein R; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Loizidou A; Department of Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Aguilar Company J; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Matas M; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Saggia C; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Chiudinelli L; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Colomba-Blameble E; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Galazi M; Cancer Division, University College London Hospitals, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Marin M; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain., Strina C; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Pla H; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Ciruelos EM; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain., Bertuzzi A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Del Mastro L; Breast Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy., Porzio G; Medical Oncology Unit, San Salvatore Hospital, L'Aquila, Italy., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Ruiz I; Department of Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Delany MB; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Eastern Piedmont and Hospital 'Maggiore della Carità', Novara, Italy., Fotia V; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Viansone A; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Chopra N; Cancer Division, University College London Hospitals, London, UK., Romeo M; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Salazar R; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain., Perez I; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., d'Avanzo F; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Franchi M; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Milani M; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Pommeret F; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Tucci M; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Ferrante D; Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale and Cancer Epidemiology, CPO Piemonte, Novara, Italy., Pinato DJ; Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK., Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Nov 02; Vol. 13, pp. 17588359211053416. Date of Electronic Publication: 2021 Nov 02 (Print Publication: 2021).